s-allylmercapto-n-acetylcysteine

S-allylmercapto-N-acetylcysteine (ASSNAC) is a synthetic compound conjugate of S-allyl mercaptan (from allicin, a garlic-derived sulfur compound) and N-acetylcysteine (NAC), a glutathione precursor. It was designed to overcome the limited tissue penetration of NAC by incorporating the lipophilic S-allyl mercaptan moiety, which enhances cellular uptake and bioavailability[1]. ASSNAC acts as a thiol-exchange compound, oxidizing cellular free sulfhydryls and releasing free NAC as a substrate for glutathione biosynthesis, while also activating the transcription factor Nrf2, leading to increased expression of phase II detoxifying enzymes and elevated cellular glutathione (GSH) levels[1][5]. These effects provide enhanced protection against oxidative stress in vascular endothelial cells and in various experimental models, and ASSNAC has been shown to extend lifespan in Caenorhabditis elegans by reducing oxidative stress-induced mortality[5]. ASSNAC is considered superior to NAC alone in up-regulating cellular glutathione and phase II detoxifying enzymes, and it has potential therapeutic applications in conditions associated with oxidative stress, although it is not yet approved for clinical use[1][5].